RE:RE: Outperform rating by National BankThe Globe and Mail reports in its Tuesday, Aug. 10, edition that CIBC World Markets analyst Kevin Chiang calls Parkland ($39.01) "an underappreciated growth story, trading at a compelling valuation." The Globe's David Leeder writes that Mr. Chiang, with an unchanged "outperformer" ranking, bumped his share target up by $2 to $51. Analysts on average target the shares at $49.77. Mr. Chiang says in a note: "Parkland's Q2 results and upward revised outlook for 2021 highlight that the company's earnings are proving to be resilient despite the impact of the pandemic on fuel demand. While the $50-million increase in Parkland's 2021 EBITDA guidance may be perceived as underwhelming given the Q2 beat, we would argue the company is being conservative in its outlook. We recognize the pandemic remains a fluid situation, especially with the spread of the Delta variant, but we remain optimistic on the broad re-opening tailwinds that should benefit Parkland as we look out into H2 and beyond." The Globe reported on Dec. 24 that iA Capital Markets analyst Elias Foscolos was maintaining his "buy" call on Parkland. He said Parkland had "supercharged its acquisition strategy." Parkland shares could then be had for $40.51.